- Investing Ideas
- /
- Global Undervalued over 20% based on DCF
Global Undervalued over 20% based on DCF
UPDATED May 08, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
5,317 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$169.38 | 3.4% | 51.6% | US$2.1t | US$191.48 | PE25.4x | E12.2% | 0.5% | Media | ||
AMZN | US$188.00 | 5.0% | 70.6% | US$2.0t | US$217.51 | PE51.9x | E21.5% | n/a | Retail | ||
2330 | NT$796.00 | 3.1% | 59.5% | NT$20.6t | NT$915.41 | PE24.1x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.883.20 | 1.2% | 52.9% | kr.3.9t | kr.908.65 | PE44.1x | E13.4% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$195.65 | 2.0% | 43.4% | US$550.6b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
WMT | US$60.30 | 2.5% | 18.6% | US$488.6b | US$65.26 | PE31.3x | E10.8% | 1.4% | Consumer Retailing | ||
700 | HK$369.80 | 2.6% | 13.3% | HK$3.4t | HK$419.57 | PE27.6x | E15.1% | 0.9% | Media | ||
JNJ | US$148.95 | -1.5% | -7.9% | US$357.9b | US$173.26 | PE21x | E6.6% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$763.41 | 5.7% | 52.8% | US$342.1b | US$776.52 | PE49.8x | E7.5% | 0.6% | Consumer Retailing | ||
600519 | CN¥1,756.00 | 3.0% | 2.3% | CN¥2.2t | CN¥2,161.67 | PE28.3x | E12.7% | 2.8% | Food, Beverage & Tobacco | ||
CVX | US$162.54 | 1.8% | 3.5% | US$299.8b | US$183.11 | PE14.8x | E2.5% | 4.0% | Energy | ||
NESN | CHF94.20 | 2.6% | -18.2% | CHF246.9b | CHF108.33 | PE22x | E7.1% | 3.2% | Food, Beverage & Tobacco | ||
KO | US$62.85 | 1.5% | -1.0% | US$269.8b | US$67.09 | PE25.1x | E7.7% | 3.1% | Food, Beverage & Tobacco | ||
CRM | US$278.97 | 3.8% | 36.2% | US$268.9b | US$337.07 | PE65.4x | E18.6% | 0.6% | Software | ||
857 | HK$7.34 | 3.4% | 35.4% | HK$1.9t | HK$7.54 | PE7.6x | E-6.0% | 6.5% | Energy | ||
PEP | US$177.41 | 1.3% | -8.7% | US$244.7b | US$187.17 | PE26.6x | E9.4% | 3.1% | Food, Beverage & Tobacco | ||
AZN | UK£122.64 | 0.9% | 2.9% | UK£190.1b | UK£133.20 | PE37.5x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
SAP | €176.46 | 4.7% | 44.3% | €204.8b | €186.58 | PE79.5x | E33.2% | 1.2% | Software | ||
WFC | US$61.23 | 2.9% | 60.0% | US$210.1b | US$63.35 | PB1.3x | E3.5% | 2.3% | Banks | ||
INTU | US$632.43 | 2.8% | 46.6% | US$179.5b | US$692.58 | PE63.9x | E17.5% | 0.6% | Software | ||
CAT | US$344.50 | 4.1% | 61.6% | US$168.7b | US$335.60 | PE15x | E-2.2% | 1.5% | Capital Goods | ||
AMGN | US$307.31 | 10.8% | 31.3% | US$161.1b | US$313.31 | PE43.8x | E17.8% | 2.9% | Pharmaceuticals & Biotech | ||
IBM | US$169.90 | 3.3% | 39.2% | US$154.7b | US$180.23 | PE19.1x | E5.4% | 3.9% | Software | ||
SIE | €181.58 | 3.6% | 22.0% | €142.3b | €190.83 | PE16.1x | E3.8% | 2.6% | Capital Goods |